VIENNA, Va., Aug. 13 /PRNewswire-FirstCall/ -- Echo Healthcare
Acquisition Corp. ("Echo" or the "Company") (OTC Bulletin Board: EHHA), a
blank check company, announced today that the Company will be presenting at
the Roth Capital Partners 5th Annual New York Conference. The conference is
being held September 5-6, 2007 at The Westin New York at Times Square in
New York City and the Company is scheduled to present at 2:30 p.m. Eastern
Time on Thursday, September 6, 2007. Chairman and Chief Executive Officer,
Gene Burleson, President and Secretary, Joel Kanter, and Chief Financial
Officer, Kevin Pendergest will be joined by Robert Wallace, Chief Executive
Officer and Steven Johnson, President and COO of XLNT Veterinary Care, Inc.
The Company recently filed a registration statement on Form S-4 with
the Securities and Exchange Commission, which contains a preliminary proxy
statement/prospectus in connection with its proposed acquisition of XLNT
Veterinary Care, Inc., a provider of veterinary primary care and
specialized services to companion animals through a network of fully-owned
veterinary hospitals. The presentation will include a discussion of XLNT's
recent financial and operational performance, an introduction of the key
new members of the management team and overview of the acquisition strategy
following the completion of the merger.
The Company will provide a live webcast of the presentation. Interested
parties may tune in to the live presentation by visiting Echo Healthcare's
web site at http://www.echohealthcare.com or by visiting
http://www.wsw.com/webcast/roth13/ehhau.ob/. A replay of the webcast will
be available for 90 days and a transcript will be filed with the Securities
Exchange Commission.
About Echo Healthcare Acquisition Corp.
Echo Healthcare Acquisition Corp. is a blank check company that was
formed on June 10, 2005 to serve as a vehicle for the acquisition of one or
more domestic or international operating businesses in the healthcare
industry. On March 22, 2006, Echo consummated its initial public offering
("IPO") of 6,250,000 Units. On March 27, 2006, the Company consummated the
closing of 937,500 additional Units subject to the underwriters'
over-allotment option. The 7,187,500 Units sold in the IPO (including the
937,500 Units subject to the underwriters' over-allotment option) were sold
at an offering price of $8.00 per Unit, which together with the private
placement of the 458,333 warrants to certain stockholders and directors of
the Company at an offering price of $1.20 per share, generated total gross
proceeds of $58,050,000. Of this amount, $54,947,000 was placed in trust.
Echo common stock trades on the OTC Bulletin Board under the symbol
EHHA.OB. To learn more about Echo, visit the website at
http://www.echohealthcare.com.
About XLNT Veterinary Care, Inc.
XLNT Veterinary Care, Inc. is a provider of veterinary primary care and
specialized services to companion animals through a network of fully-owned
veterinary hospitals. XLNT currently owns and operates 26 veterinary
hospitals in the state of California.
Additional Information about the Merger and Where to Find It
Echo has filed a Registration Statement on Form S-4 with the Securities
and Exchange Commission ("SEC") in connection with the merger, and expects
to mail a Proxy Statement/Prospectus to stockholders of Echo concerning the
proposed merger transaction after the Registration Statement is declared
effective by the SEC. INVESTORS AND SECURITY HOLDERS OF ECHO ARE URGED TO
READ THE REGISTRATION STATEMENT AND PROXY STATEMENT/PROSPECTUS AND THE
OTHER RELEVANT MATERIALS CAREFULLY WHEN THEY BECOME AVAILABLE BECAUSE THEY
WILL CONTAIN IMPORTANT INFORMATION ABOUT ECHO, XLNT, THE MERGER AND RELATED
MATTERS. Investors and security holders will be able to obtain the
documents free of charge at the SEC's web site at http://www.sec.gov. In
addition, investors and security holders may obtain free copies of the
documents filed with the SEC by Echo by directing a written request to:
Corporate Secretary, Echo Healthcare Acquisition Corp., 8000 Towers
Crescent Drive, Suite 1300, Vienna, VA 22182. Investors and security
holders are urged to read the proxy statement/ prospectus and the other
relevant materials when they become available before making any voting or
investment decision with respect to the merger.
In addition to the Registration Statement and Proxy
Statement/Prospectus, Echo files annual, quarterly and special reports,
proxy statements and other information with the SEC. You may read and copy
any reports, statements or other information filed by Echo at the SEC
public reference room at 100 F Street, N.E., Washington, D.C. 20549. Please
call the SEC at 1-800-SEC-0330 for further information on the public
reference room. Echo's filings with the SEC are also available to the
public from commercial document-retrieval services and at the SEC's web
site at http://www.sec.gov.
A registration statement relating to the securities to be offered in
the merger has been filed with the SEC but has not yet become effective.
These securities may not be sold nor may offers to buy be accepted prior to
the time the registration statement becomes effective. This press release
shall not constitute an offer to sell or the solicitation of an offer to
buy nor shall there be any sale of these securities in any state in which
such offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state.
Interests of Certain Persons in the Merger
Echo will be soliciting proxies from the stockholders of Echo in
connection with the merger and issuance of shares of Echo common stock in
the merger. In addition, Morgan Joseph & Co. Inc. ("Morgan Joseph"), Roth
Capital Partners, LLC ("Roth"), the directors and executive officers of
Echo and the directors, officers and affiliates of XLNT may also be deemed
to be participants in the solicitation of proxies. Information about the
directors and executive officers of Echo, Morgan Joseph and Roth is set
forth in the prospectus filed on March 17, 2006. Information about the
directors and executive officers of XLNT as well as updated information
about Morgan Joseph, Roth and the directors and officers of Echo will be
included in the Proxy Statement/Prospectus. Morgan Joseph, Roth, the
directors and executive officers of Echo and XLNT have interests in the
merger, some of which may differ from, or may be in addition to those of
the respective stockholders of Echo generally. Those interests will be
described in greater detail in the Proxy Statement/Prospectus with respect
to the merger, which may include potential fees to Morgan Joseph and Roth,
employment relationships, potential membership on the Echo Board of
Directors, option and stock holdings and indemnification.
Safe Harbor Statement
Except for the historical information contained herein, certain matters
discussed in the accompanying interview transcript, including statements as
to the expected benefits of the combination of the two companies, future
product and service offerings, expected synergies, and timing of closing,
are forward-looking statements within the meaning of the "safe harbor"
provisions of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements are subject to risks and uncertainties that may
cause actual results to differ materially, including, but not limited to,
the satisfaction of certain conditions to closing of the proposed merger,
including the risk that stockholder approval might not be obtained in a
timely manner or at all, the ability to successfully integrate the two
companies and achieve expected synergies following the merger, the ability
of the combined company to successfully acquire, integrate and operate
veterinary hospitals and clinics, requirements or changes affecting the
businesses in which XLNT is engaged, veterinary services trends, including
factors affecting supply and demand, dependence on acquisitions for growth,
labor and personnel relations, changing interpretations of generally
accepted accounting principles and other risks detailed from time to time
in the SEC reports of Echo, including its Form 10-K and 10-Q filings, and
its prospectus filed with the SEC on March 17, 2006. These forward-looking
statements speak only as of the date hereof. Echo disclaims any intention
or obligation to update or revise any forward-looking statements.
Filed by Echo Healthcare Acquisition Corp. (Commission File No.
000-51596) Pursuant to Rule 425 under the Securities Act of 1933, as
amended, and deemed filed pursuant to Rule 14a-12 of the Securities
Exchange Act of 1934, as amended
Subject Company: XLNT Veterinary Care, Inc.
For Further Information:
AT ECHO HEALTHCARE: AT FINANCIAL RELATIONS BOARD:
Joel Kanter Erin Cox
President and Secretary General Information
Echo Healthcare Acquisition Corp. (213) 486-6549
(703) 760-7888 ecox@frbir.com
SOURCE Echo Healthcare Acquisition Corp.
 back to top
Related links:
http://www.echohealthcare.com
CONTACT:
Joel Kanter, President and Secretary of Echo
Healthcare Acquisition Corp., +1-703-760-7888; or Erin Cox,
General Information, of Financial Relations Board,
+1-213-486-6549, ecox@frbir.com, for Echo Healthcare Acquisition
Corp.
|
